THE APPEARANCE OF THE THYMUS AND THE INTEGRATED EVOLUTION OF ADAPTIVE IMMUNE AND NEUROENDOCRINE SYSTEMS

REFERENCES

• Hammar JA.The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology 1921; 5: 543–573.
   Google Scholar
• Burnet FM. Role of the thymus and related organs in immunity. Br Med J 1962; 2: 807–811.
   PubMedGoogle Scholar
• Miller JFAP. Role of the thymus in murine leukaemia. Nature 1959; 183: 1069.
   Web of Science ®Google Scholar
• Miller JFAP. Immunological function of the thymus. Lancet 1961; 2: 748–749.
   PubMed Web of Science ®Google Scholar
• Kisielow P, BlOthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+CD8+ thymocytes. Nature 1988; 333: 156–159.
   Google Scholar
• Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1988; 49: 273–280.
   Web of Science ®Google Scholar
• Geenen V, Legros JJ, Franchimont P, Baudrihaye M, Defresne MP, Boniver J. The neuroendocrine thymus: Coexistence of oxytocin and neurophysin in the human thymus. Science 1986; 232:508–511.
   PubMed Web of Science ®Google Scholar
• Geenen V, Robert F, Legros JJ et al. Neuroendocrine-Immunology: from sys-temic interactions to the immune tolerance of self neuroendocrine functions. Acta Clin Belg 1991; 46: 135–141.
   Web of Science ®Google Scholar
• Geenen V. Goxe B, Martens H et al. Cryptocrine signaling in the thymus network and T cell education to neuroendocrine self-antigens. J Mol Med 1995; 73:449–455.
   Web of Science ®Google Scholar
• Martens H, Goxe B, Geenen V. The thymic repertoire of neuroendocrine-related self-antigens: Physiological implications in T-cell life and death. Immunol Today 1996; 17: 312–317.
   PubMedGoogle Scholar
• Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006; 24: 571–606.
   PubMed Web of Science ®Google Scholar
• Nagamine K, Peterson P. Scott HS, et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393–398.
   PubMed Web of Science ®Google Scholar
• Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genetics 1997; 17: 399–403.
   PubMed Web of Science ®Google Scholar
• Sakagushi S, Sakagushi N, Asano N, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immuno11995; 155: 1151–1164.
   Google Scholar
• Fontenot JD, Gavin MA, Rudensky A. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330–336.
   PubMed Web of Science ®Google Scholar
• Heddon B, Mason D. The third function of the thymus. Trends Immunol 2000; 21: 95–99.
   Google Scholar
• Bennett AR, Farley A, Blair NF, Gordon J, Sharp L, Blackburn CC. Identification and characterization of thymic epithelial progenitor cells. Immunity 2002; 16: 803–814.
   PubMed Web of Science ®Google Scholar
• Rossi S, Jenkinson W, Anderson G, Jenkinson EJ. Clonal analysis reveals a com-mon progenitor for cortical and medullary epithelium. Nature 2006; 441: 988–991.
   PubMed Web of Science ®Google Scholar
• Anderson G, Lane PJ, Jenkinson EJ. Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol 2007; 7:954–963.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Eastman QM, Schatz DG. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 1998; 394: 744–751.
   PubMed Web of Science ®Google Scholar
• Boehm T, Bleul CC. The evolutionary history of lymphoid organs. Nat Immunol 2007; 8: 131–135.
   Web of Science ®Google Scholar
• Hirano M, Das S, Guo P. Cooper MD. The evolution of adaptive immunity in vertebrates. Adv Immunol 2011; 109:125–157.
   PubMed Web of Science ®Google Scholar
• Bajoghli B, Guo P. Aghaallaei N et al. A thymus candidate in lampreys. Nature 2011; 470: 90–95.
   PubMed Web of Science ®Google Scholar
• Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 2009; 9: 833–844.
   PubMed Web of Science ®Google Scholar
• Ericsson A, Geenen V, Robert F et al. Expression of preprotachykinin-A and neuropeptide-Y in mRNA of the thymus. Mol Endocrinol 1990; 4: 1211–1218.
   PubMed Web of Science ®Google Scholar
• Geenen V. Achour I, Robert F, et al. Evidence that insulin-like growth factor 2 (IGF-2) is the dominant thymic member of the insulin superfamily. Thymus 1993; 21: 115–127.
   Google Scholar
• Jolicceur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994; 91: 6707–6711.
   Web of Science ®Google Scholar
• Vanneste Y, Ntodou Thome A, Vandersmissen E et al. Identification of neu roten-sin-related peptides in human thymic epithelial cell membranes and relation-ship with major histocompatibility complex class I molecules. J Neuroimmunol 1997; 76:161–166.
   PubMed Web of Science ®Google Scholar
• Sospedra M, Ferrer-Francesch X, Dominguez O, Juan M, Foz-Sala M, Pujol-Borrell R. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol 1998; 161:5918–5929.
   Web of Science ®Google Scholar
• Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in med-ullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032–1039.
   PubMed Web of Science ®Google Scholar
• Ashton-Rickardt PG, Bandeira A, Delaney JR et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994; 74: 651–663.
   Google Scholar
• Hansenne I, Rasier G, Pequeux C et al. Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network. J Neuroim-munol 2005; 158: 67–75.
   PubMed Web of Science ®Google Scholar
• Hansenne I, Renard-Charlet C, Greimers R, Geenen V. Dendritic cell differentia-tion and tolerance to insulin-related peptides in Igf2-deficient mice. J Immunol 2006; 176: 4651–4657.
   Web of Science ®Google Scholar
• Burnet FM. A reassessment of the forbidden clone hypothesis of autoimmune diseases. Aust J Exp Biol Med 1973; 50: 1–9.
   Google Scholar
• Georgiou HM, Mandel TE. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation. Diabetes 1995; 44:49–59.
   Web of Science ®Google Scholar
• Kecha-Kamoun O, Achour I, Martens H et al. Thymic expression of insulin-related genes in an animal model of type 1 diabetes. Diab Metab Rev 2001; 17: 146–152.
   PubMed Web of Science ®Google Scholar
• Chentoufi A, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002; 41: 1383–1390.
   Google Scholar
• Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow in the thymus by the Aire protein. Science 2002; 298: 1395–1401.
   PubMed Web of Science ®Google Scholar
• Ramsey C, Winqvist O, Puhakka M et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11: 397–409.
   PubMed Web of Science ®Google Scholar
• Paschke R, Geenen V. Messenger RNA expression for a TSH receptor variant in the thymus of a two-year-old child. J Mol Med 1995; 73: 577–580.
   Web of Science ®Google Scholar
• Murakami M; Hosoi Y, Negishi T et al. Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 1996; 98: 2228–2234.
   Web of Science ®Google Scholar
• Colobran R, del Pilar Armengol M, Faner R et al. Association of an SNP with intrathymic transcription of TSHR and Graves disease: a role for defective thymic tolerance. Hum Mol Genet 2011; doi:10.1093/hmg/ddr247.
   Web of Science ®Google Scholar
• Lv H, Havari E, Pinto S et al. Impaired thymic tolerance to a-myosin directs auto-immunity to the heart in mice and humans. J Clin Invest 2011; 21: 1561–1573.
   Google Scholar
• Geenen V. Mottet M, Dardenne O et al. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Curr Opin Phar-macol 2010; 10:461–472.
   PubMed Web of Science ®Google Scholar
• Chentoufi AA, Geenen V. Thymic self-antigen expression for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Clin Dev Immunol 2011; doi:10.1155/2011/349368.
   Web of Science ®Google Scholar
• Geenen V, Chrousos GP. lmmunoendocrinology in Health and Disease. Marcel Dekker Ltd, New York, USA, 2004.
   Google Scholar
• Gonzalez-Rey E, Chomy A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007; 7: 52–63.
   PubMed Web of Science ®Google Scholar
• Smith P. The effect of hypophysectomy upon the involution of the thymus in the rat. Anat Rec 1930; 47: 119–143.
   Google Scholar
• Kelley KW, Weigent DA, Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007; 21: 384–392.
   PubMed Web of Science ®Google Scholar
• Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocr Rev 2000; 21: 412–443.
   PubMed Web of Science ®Google Scholar
• Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Phar-macol 2010; 10:408–424.
   PubMed Web of Science ®Google Scholar
• Morrhaye G, Kermani H, Legros JJ et al. Impact of growth hormone (GH) defi-ciency and GH replacement upon thymus function in adult patients. PLoS ONE 2009; 4: e5668.
   Google Scholar
• Napolitano LA, Schmidt D, Gotway MB et al. Growth hormone enhances thymic function in HIV-1-infected patients. J Clin Invest 2008; 118: 1085–1098.
   PubMed Web of Science ®Google Scholar
• Castermans E, Hannon M, Dutrieux J et al. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is lim-ited to patients younger than 60 years of age. Haematologica 2011; 96:298–306.
   PubMed Web of Science ®Google Scholar